XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning (unaudited) at Dec. 31, 2023 $ 54,000 $ 306,187,000 $ 529,000 $ (283,290,000) $ 23,480,000
Balance at the beginning (unaudited) (in shares) at Dec. 31, 2023 54,240,265        
Stock-based compensation   1,949,000     1,949,000
Issuance of common stock offerings, net of fees incurred   53,000     53,000
Issuance of common stock offerings, net of fees incurred (in shares) 53,290        
Warrants issued in connection with long-term debt   691,000     691,000
Foreign translation adjustment     1,644,000   1,644,000
Issuance of restricted stock units   (6,000)     (6,000)
Issuance of restricted stock units (in shares) 12,860        
Net Income (Loss)       (10,384,000) (10,384,000)
Balance at the end (unaudited) at Jun. 30, 2024 $ 54,000 308,874,000 2,173,000 (293,674,000) 17,427,000
Balance at the end (unaudited) (in shares) at Jun. 30, 2024 54,306,415        
Balance at the beginning (unaudited) at Mar. 31, 2024 $ 54,000 307,200,000 1,752,000 (289,380,000) 19,626,000
Balance at the beginning (unaudited) (in shares) at Mar. 31, 2024 54,293,555        
Stock-based compensation   989,000     989,000
Warrants issued in connection with long-term debt   691,000     691,000
Foreign translation adjustment     421,000   421,000
Issuance of restricted stock units   (6,000)     (6,000)
Issuance of restricted stock units (in shares) 12,860        
Net Income (Loss)       (4,294,000) (4,294,000)
Balance at the end (unaudited) at Jun. 30, 2024 $ 54,000 308,874,000 2,173,000 (293,674,000) 17,427,000
Balance at the end (unaudited) (in shares) at Jun. 30, 2024 54,306,415        
Balance at the beginning (unaudited) at Dec. 31, 2024 $ 55,000 310,809,000 4,252,000 (304,009,000) 11,107,000
Balance at the beginning (unaudited) (in shares) at Dec. 31, 2024 54,830,146        
Stock-based compensation $ 1,000 1,390,000     1,391,000
Stock-based compensation (in shares) 113,231        
Issuance of common stock from exercise of warrants $ 1,000 1,438,000     1,439,000
Issuance of common stock from exercise of warrants (in shares) 1,417,208        
Issuance of common stock and warrants from rights offerings, net of fees incurred $ 6,000 5,386,000     5,392,000
Issuance of common stock and warrants from rights offerings, net of fees incurred (in shares) 6,249,791        
Foreign translation adjustment     (8,212,000)   (8,212,000)
Net Income (Loss) $ 0 0 0 469,000 469,000
Balance at the end (unaudited) at Jun. 30, 2025 $ 63,000 319,023,000 (3,960,000) (303,540,000) 11,586,000
Balance at the end (unaudited) (in shares) at Jun. 30, 2025 62,610,376        
Balance at the beginning (unaudited) at Mar. 31, 2025 $ 63,000 318,452,000 1,516,000 (305,487,000) 14,544,000
Balance at the beginning (unaudited) (in shares) at Mar. 31, 2025 62,529,466        
Stock-based compensation   571,000     571,000
Stock-based compensation (in shares) 80,910        
Foreign translation adjustment     (5,476,000)   (5,476,000)
Net Income (Loss) $ 0 0 0 1,947,000 1,947,000
Balance at the end (unaudited) at Jun. 30, 2025 $ 63,000 $ 319,023,000 $ (3,960,000) $ (303,540,000) $ 11,586,000
Balance at the end (unaudited) (in shares) at Jun. 30, 2025 62,610,376